Senior Manager, Clinical Scientist, Hematology
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Manager, Clinical Scientist to join our Clinical Sciences team, supporting rare hematologic conditions and/or immunologic diseases. In this role, you will lead the design, execution, and interpretation of clinical studies within a cross-functional matrix environment while collaborating closely with Medical Directors, Clinical Study Teams, and Global Clinical SubTeams to advance early- and late-stage development programs.
Job description
When & where
- Location: Tarrytown, NY, or Warren, NJ
- Work model/flexibility: Primarily on-site with hybrid flexibility
Discover your role
- Lead clinical study design, execution, and data interpretation across a full development program
- Partner with Medical Directors and cross-functional teams to shape study strategy and scientific direction
- Author and review key clinical documents, including protocols, amendments, and clinical study reports
- Drive medical and safety data review to protect patient safety throughout the trial lifecycle
- Apply deep therapeutic area knowledge to inform study design and risk mitigation
- Represent Clinical Sciences in scientific advisory boards, steering committees, and safety monitoring meetings
- Mentor and guide junior team members as part of a growing Clinical Sciences function
- Ensure compliance with FDA, EMEA, ICH, and GCP standards across all study activities
This role might be for you
- Bachelor's degree required; advanced degree (PhD/MD/PharmD/MSc) in life sciences or healthcare preferred
- 8+ years of pharmaceutical clinical drug development experience
- Experience in rare hematologic conditions and/or immunologic diseases preferred
- Demonstrated knowledge of GCP, clinical study design, and clinical research methodology
- Proven track record driving clinical trial process improvements
- Bring strong scientific and analytical skills to complex clinical development challenges
- Are energized by contributing to therapies for rare and underserved patient populations
Requirements
- Bachelor's degree required
- Advanced degree (PhD/MD/PharmD/MSc) in life sciences or healthcare preferred
- 8+ years of pharmaceutical clinical drug development experience
- Experience in rare hematologic conditions and/or immunologic diseases preferred
- Demonstrated knowledge of GCP, clinical study design, and clinical research methodology
- Proven track record driving clinical trial process improvements
- Strong scientific and analytical skills
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.